More than two years after the public debut of ChatGPT, software companies still haven’t found a compelling way of charging for AI tools, chief information officers say. Now they’re trying new ...
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.
A $10.3 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, will fund ...
The developer of the chatbot that shocked U.S. incumbents had access to Nvidia chips that its parent company providentially ...
SemiAnalysis debunks the $6 million DeepSeek AI training cost myth, revealing a massive $1.3 billion investment in ...
January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...
Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback